Arch Therapeutics, Inc.
ARTHDelisted- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001537561
Arch Therapeutics, Inc. was delisted in 2022; its insiders filed their last Form 4 on Sep 8, 2023; 1 institution reported holding it in 13F filings for Q3 2022, worth $0 in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 1
- Q3 2022, −1 vs. previous quarter
- 13F value
- $0
- Reported value at the end of Q3 2022
- Superinvestors holding
- 0
- At the end of Q3 2022
Superinvestors holding ARTH, Q3 2022
No superinvestor reported holding ARTH at the end of Q3 2022.
Latest insider trades
Open-market purchases and sales by Arch Therapeutics, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2023 (view filing)5:47 PM ET | Aug 31 | 8 daysLate | Abrams Michael SCHIEF FINANCIAL OFFICER | PPurchase | +10.3K | $0.275 | +$2.83K | New position10.3K after | Duplicate filing |
| Sep 8, 2023 (view filing)5:47 PM ET | Aug 31 | 8 daysLate | Norchi Terrence WPRESIDENT AND CHIEF EXECUTIVE | PPurchase | +6.86K | $0.275 | +$1.89K | New position6.86K after | |
| Sep 8, 2023 (view filing)5:47 PM ET | Aug 31 | 8 daysLate | Hicks LaurenceDirector | PPurchase | +10.3K | $0.275 | +$2.83K | New position10.3K after |
Top 10 13F holders, Q3 2022
The largest institutional positions in Arch Therapeutics, Inc. at the end of Q3 2022; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bryn Mawr Trust Co | 15,000 | $0 | 0.00% | 00.0% | Unchanged |